Kura Oncology, Inc. Contracts & Agreements

Form of Pre-Funded Warrant (Filed With SEC on January 26, 2024)

Securities Purchase Agreement, dated January 24, 2024, by and among Kura Oncology, Inc. and the persons party thereto (Filed With SEC on January 26, 2024)

Registration Rights Agreement, dated January 26, 2024, by and among Kura Oncology, Inc. and the persons party thereto (Filed With SEC on January 26, 2024)

Executive Employment Agreement, effective as of August 14, 2023, by and between the Registrant and Brian Powl (Filed With SEC on November 2, 2023)

First Amendment to Lease, dated as of August 30, 2023, by and between the Registrant and East Office Operating Limited Partnership (Filed With SEC on November 2, 2023)

First Amendment to Loan and Security Agreement, dated as of October 2, 2023, by and between the Registrant and Hercules Capital, Inc (Filed With SEC on November 2, 2023)

Sales Agreement, dated November 2, 2023, by and among the Registrant, Leerink Partners LLC and Cantor Fitzgerald & Co (Filed With SEC on November 2, 2023)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 9, 2023)

Form of International Stock Option Grant Notice, International Stock Option Agreement and International Notice of Exercise under the Kura Oncology, Inc. Amended and Restated 2014... (Filed With SEC on August 9, 2023)

Underwriting Agreement, dated June 13, 2023, by and among Kura Oncology, Inc., BofA Securities, Inc., Jefferies LLC and SVB Securities LLC, as representatives of the several... (Filed With SEC on June 14, 2023)

Form of Pre-Funded Warrant (Filed With SEC on June 14, 2023)

Form of Warrant Agreement issued by Kura Oncology, Inc. on November 2, 2022 to Hercules Capital, Inc. and certain other Lenders (Filed With SEC on November 3, 2022)

Securities Purchase Agreement dated as of November 2, 2022 by and between Kura Oncology, Inc. and Bristol-Myers Squibb Company (Filed With SEC on November 3, 2022)

Loan and Security Agreement dated as of November 2, 2022 by and between Kura Oncology, Inc. and Hercules Capital, Inc (Filed With SEC on November 3, 2022)

Form of International Restricted Stock Unit Award Grant Notice and International Restricted Stock Unit Award Agreement under the Kura Oncology, Inc. Amended and Restated 2014... (Filed With SEC on February 24, 2022)

Executive Employment Agreement, effective as of October 18, 2021, by and between the Registrant and Teresa Bair (Filed With SEC on February 24, 2022)

Separation Agreement, effective as of February 4, 2022, by and between the Registrant and Marc Grasso, M.D (Filed With SEC on February 24, 2022)

Sales Agreement, dated February 24, 2022, by and among Kura Oncology, Inc., SVB Securities LLC, Credit Suisse Securities (USA) LLC and Cantor Fitzgerald & Co (Filed With SEC on February 24, 2022)

Lease Agreement, dated May 11, 2021, by and between the Registrant and BP3-SD5 5510 Morehouse Drive LLC (Filed With SEC on August 5, 2021)

First Amendment to Amended and Restated Executive Employment Agreement, effective as of June 30, 2021, by and between the Registrant and Bridget Martell (Filed With SEC on August 5, 2021)

Executive Employment Agreement, effective as of January 6, 2020, by and between the Registrant and Kirsten Flowers (Filed With SEC on May 6, 2021)

Executive Employment Agreement, effective as of February 10, 2020, by and between the Registrant and Bridget Martell (Filed With SEC on May 6, 2021)

Amended and Restated Executive Employment Agreement, effective as of August 24, 2020, by and between the Registrant and Bridget Martell (Filed With SEC on May 6, 2021)

Executive Employment Agreement, effective as of July 22, 2020, by and between the Registrant and Stephen Dale, M.D (Filed With SEC on May 6, 2021)

Amendment to Executive Employment Agreement, effective as of February 22, 2021, by and between the Registrant and Stephen Dale, M.D (Filed With SEC on May 6, 2021)

License Agreement, dated December 18, 2014, by and between the Registrant and Janssen Pharmaceutica NV (Filed With SEC on February 24, 2021)

Amended and Restated Asset Purchase Agreement, dated February 12, 2015, by and between the Registrant and Araxes Pharma LLC (Filed With SEC on February 24, 2021)

Patent License Agreement, effective as of December 22, 2014, by and between the Registrant and the Regents of the University of Michigan, as amended on March 3, 2015, July 22,... (Filed With SEC on February 24, 2021)

Fifth Amendment to Patent License Agreement, effective as of May 24, 2017, by and between the Registrant and the Regents of the University of Michigan (Filed With SEC on February 24, 2021)

Services Agreement, effective as of October 1, 2014, by and between the Registrant and Wellspring Biosciences, Inc (Filed With SEC on February 24, 2021)

Management Services Agreement, effective as of October 1, 2014, by and between the Registrant and Araxes Pharma LLC (Filed With SEC on February 24, 2021)

Master Collaboration Agreement, dated January 4, 2021 by and between the Registrant and Illumina, Inc (Filed With SEC on February 24, 2021)

Second Amendment to Executive Employment Agreement, effective as of February 19, 2021, by and between the Registrant and Troy E. Wilson, Ph.D., J.D (Filed With SEC on February 24, 2021)

Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the Kura Oncology, Inc. Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on February 24, 2021)

Underwriting Agreement, dated December 8, 2020, by and among Kura Oncology, Inc., SVB Leerink LLC, Credit Suisse Securities (USA) LLC, Barclays Capital Inc., and Stifel, Nicolaus... (Filed With SEC on December 9, 2020)

Form of International Stock Option Grant Notice, International Stock Option Agreement and International Notice of Exercise under the Kura Oncology, Inc. Amended and Restated... (Filed With SEC on November 5, 2020)

Second Amendment to Office Lease Agreement, dated October 27, 2020 by and between the Registrant and BRE CA Office Owner LLC (Filed With SEC on November 5, 2020)

Amended and Restated Nonemployee Director Compensation Policy (Filed With SEC on August 6, 2020)

Underwriting Agreement, dated May 5, 2020, by and among Kura Oncology, Inc., SVB Leerink LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on May 6, 2020)

Executive Employment Agreement, effective as of November 4, 2019, by and between the Registrant and James Basta (Filed With SEC on May 4, 2020)

Separation Agreement, dated August 21, 2019, by and between the Registrant and John Farnam (Filed With SEC on May 4, 2020)

Office Lease Agreement, dated March 24, 2020, by and between the Registrant and East Office Operating Limited Partnership (Filed With SEC on May 4, 2020)

Second Amendment to Sublease, dated April 22, 2020 by and between the Registrant and Araxes Pharma LLC (Filed With SEC on May 4, 2020)

First Amendment to Office Lease Agreement, dated May 2, 2020 by and between the Registrant and BRE CA Office Owner LLC (Filed With SEC on May 4, 2020)

First Amendment to Loan and Security Agreement, dated April 3, 2020, by and between Kura Oncology, Inc. and Silicon Valley Bank (Filed With SEC on April 7, 2020)

Description of Registrants Common Stock (Filed With SEC on February 25, 2020)

Office Lease Agreement, dated January 8, 2020, by and between the Registrant and BRE CA Office Owners LLC (Filed With SEC on February 25, 2020)

Separation Agreement, dated February 5, 2020, by and between the Registrant and Antonio Gualberto, M.D., Ph.D (Filed With SEC on February 25, 2020)

Assignment and Assumption of Sublease, dated August 2, 2019, by and among the Registrant, Wellspring Biosciences, Inc. and Araxes Pharma LLC (Filed With SEC on November 5, 2019)

First Amendment to Executive Employment Agreement, effective as of August 21, 2018, by and between the Registrant and Marc Grasso, M.D (Filed With SEC on November 5, 2019)

Executive Employment Agreement, effective as of August 9, 2019, by and between the Registrant and Kathleen Ford (Filed With SEC on November 5, 2019)

Underwriting Agreement, dated June 18, 2019, by and among Kura Oncology, Inc. and SVB Leerink LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on June 19, 2019)

First Amendment to Sublease, dated March 1, 2019, by and between the Registrant and Wellspring Biosciences, Inc (Filed With SEC on March 5, 2019)

Sales Agreement, dated March 5, 2019, by and among Kura Oncology, Inc., SVB Leerink LLC and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on March 5, 2019)

Executive Employment Agreement, effective as of August 21, 2018, by and between the Registrant and Marc Grasso, M.D (Filed With SEC on November 5, 2018)

Loan and Security Agreement, dated as of November 1, 2018, by and among the Registrant and Silicon Valley Bank (Filed With SEC on November 5, 2018)

Executive Employment Agreement, effective as of July 1, 2018, by and between the Registrant and John Farnam (Filed With SEC on August 6, 2018)

Underwriting Agreement, dated June 27, 2018, by and between Kura Oncology, Inc. and Leerink Partners LLC, as representative of the several underwriters named therein (Filed With SEC on June 28, 2018)

Second Amendment to Management Services Agreement, effective as of April 1, 2018, by and between the Registrant and Araxes Pharma LLC (Filed With SEC on May 8, 2018)

Kura Oncology, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 12, 2018)

Sixth Amendment to Patent License Agreement, effective as of August 24, 2017, by and between the Registrant and the Regents of the University of Michigan (Filed With SEC on March 12, 2018)

Amended and Restated Executive Employment Agreement, effective as of January 29, 2016, by and between the Registrant and Heidi Henson (Filed With SEC on March 12, 2018)

Amended and Restated Sales Agreement, dated March 12, 2018, by and between Kura Oncology, Inc. and Cowen and Company, LLC (Filed With SEC on March 12, 2018)

Sales Agreement, dated January 27, 2017, by and between Kura Oncology, Inc. and Cowen and Company, LLC, as amended on November 9, 2017 (Filed With SEC on November 9, 2017)

Second Amendment to Loan and Security Agreement, dated October 12, 2017, by and between the Registrant, Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on November 7, 2017)

7,700,000Shares KURA ONCOLOGY, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on August 11, 2017)

FIFTH AMENDMENT TO PATENT LICENSE AGREEMENT (Filed With SEC on August 7, 2017)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 15, 2017)

SUBLEASE (Filed With SEC on March 14, 2017)

THIRD AMENDMENT TO SUBLEASE (Filed With SEC on March 14, 2017)

PATENT LICENSE AGREEMENT (Filed With SEC on March 14, 2017)

KURA ONCOLOGY, INC. $25,000,000 COMMONSTOCK SALES AGREEMENT (Filed With SEC on January 27, 2017)

WARRANT TO PURCHASE STOCK (Filed With SEC on August 10, 2016)

FIRST AMENDMENT TO MANAGEMENT SERVICES AGREEMENT (Filed With SEC on August 10, 2016)

LOAN AND SECURITY AGREEMENT (Filed With SEC on August 10, 2016)

AMENDMENT No. 1 TO LICENSE AGREEMENT (Filed With SEC on August 10, 2016)

2nd AMENDMENT TO SUBLEASE (Filed With SEC on August 10, 2016)

Kura Oncology, Inc. Amended and Restated Executive Employment Agreement for Troy E. Wilson (Filed With SEC on March 17, 2016)

Kura Oncology, Inc. Amended and Restated Executive Employment Agreement for Antonio Gualberto (Filed With SEC on March 17, 2016)

Kura Oncology, Inc. Amended and Restated Executive Employment Agreement for Annette North (Filed With SEC on March 17, 2016)

Kura Oncology, Inc. [] Shares1 Common Stock ($0.0001 parvalue) Underwriting Agreement (Filed With SEC on October 28, 2015)

KURA ONCOLOGY, INC. AMENDED AND RESTATED NON-EMPLOYEE DIRECTORCOMPENSATION POLICY (Filed With SEC on October 20, 2015)

OFFICE LEASE AGREEMENT 55 CAMBRIDGEPARKWAY CAMBRIDGE, MA by and between 55CAMBRIDGE PARKWAY, LLC, a Delaware limited liability company, as Landlord and Kura Oncology,Inc., a... (Filed With SEC on October 20, 2015)

LICENSE AGREEMENT (Filed With SEC on July 2, 2015)

SERVICESAGREEMENT (Filed With SEC on June 2, 2015)

MANAGEMENTSERVICES AGREEMENT (Filed With SEC on June 2, 2015)

First Amendment to Executive Employment Agreement (Filed With SEC on May 13, 2015)

KURA ONCOLOGY, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on April 17, 2015)

AGREEMENT AND PLAN OF MERGER by and among KURA ONCOLOGY, INC., ZETA ACQUISITION CORP. III AND KURA OPERATIONS, INC. March 6, 2015 AGREEMENT AND PLAN OF MERGER (Filed With SEC on March 12, 2015)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on March 12, 2015)

Additional abbreviations may also be used though not in the above list. (Filed With SEC on March 12, 2015)

KURA ONCOLOGY, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 12, 2015)

KURA ONCOLOGY, INC. AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN AMENDED AND RESTATED BY THE BOARD:MARCH 6, 2015 APPROVED BY THE STOCKHOLDERS:MARCH 6, 2015 (Filed With SEC on March 12, 2015)

KURA ONCOLOGY, INC. RESTRICTED STOCK PURCHASE AWARD NOTICE (AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN) (Filed With SEC on March 12, 2015)

KURA ONCOLOGY, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 6, 2015 APPROVED BY THE STOCKHOLDERS:MARCH 6, 2015 (Filed With SEC on March 12, 2015)

INDEMNIFICATION AGREEMENT (Filed With SEC on March 12, 2015)

KURA ONCOLOGY, INC. EXECUTIVE EMPLOYMENT AGREEMENT FOR TROY WILSON (Filed With SEC on March 12, 2015)

LICENSE AGREEMENT (Filed With SEC on March 12, 2015)

AMENDED AND RESTATED ASSET PURCHASE AGREEMENT (Filed With SEC on March 12, 2015)

SUBLEASE (Filed With SEC on March 12, 2015)

1st AMENDMENT TO SUBLEASE (Filed With SEC on March 12, 2015)

REDEMPTION AGREEMENT (Filed With SEC on March 12, 2015)

INDEMNITY AGREEMENT (Filed With SEC on March 12, 2015)

PROMISSORY NOTE (Filed With SEC on August 14, 2013)

Category

Industry

Companies

Contracts

Kura Oncology, Inc. Contracts & Agreements